Clawbacks And Clinical Trial Set Up Are Among UK’s Investment Deterrents

 
• By Francesca Bruce
  
The ABPI hopes that its new competitiveness framework will inspire policy change that makes the UK more attractive. (Shutterstock)

More from Market Access

More from United Kingdom